
|Articles|November 12, 2021
- CURE® Lung Cancer Heroes® 2021 Essay Book
- Volume 2
Guiding the Way for Patients With Lung Cancer: 'He Is my Hero'
Author(s)Timothy J. Barry
A lung cancer survivor shares a heartfelt tribute to Dr. Abraham Chachoua, who changed his life.
Advertisement
I was diagnosed with lung cancer in 2011. It didn’t look good. Dr. Abraham Chachoua kept me alive long enough to get me into the 2015 drug trial for Opdivo (nivolumab) at Memorial Sloan Kettering Cancer Center. I had such bad side effects that I didn’t finish the trial. But it worked.
My last CT scan showed no cancer. He is my hero.
For more news on cancer updates, research and education, don’t forget to
Articles in this issue
almost 5 years ago
A Deep Dedication to Improving Outcomes for Patients With Lung Canceralmost 5 years ago
Breaking the Stigma: Anyone Can Get Lung Canceralmost 5 years ago
The Lung Cancer Advocate Who Is a Friend to Allalmost 5 years ago
Rock Star Lung Cancer Supporter and Advocatealmost 5 years ago
My Wife’s Oncologist Is a Heroalmost 5 years ago
A Champion for Expanding Access to Lung Cancer Breakthroughsalmost 5 years ago
Lung Cancer Research Advocacy Driven by Heartalmost 5 years ago
When a Lung Cancer Diagnosis Brings About a New Missionalmost 5 years ago
Lung Cancer Hero Implements ‘Tar Wars’ School Initiative Programalmost 5 years ago
Making Cancer Medicine More CompassionateAdvertisement
Related to this article

For people who already have cancer, quitting smoking can help treatment work and the body heal, and the National Cancer Institute says it improves the outlook for cancer patients. Here is what quitting can do and where to find free help.

The FDA granted accelerated approval to Nelkarmi for adults with advanced ALK-positive non-small cell lung cancer that grew after prior ALK-targeted drugs.

For Lung Cancer Awareness Month, five numbers from federal and American Cancer Society data show how survival for people with lung cancer has changed, how it differs by stage and type, and how many people are living with the disease.

Vicki McGrath, a Bay Area Cancer Connections board member, talks about fatigue, fear of movement and the role of peer support in post-surgery exercise.

At its 23rd annual conference, Bay Area Cancer Connections described how donations and volunteers fund services for people facing cancer’s medical, financial and practical costs.

On World Pancreatic Cancer Day, here are five numbers from the American Cancer Society's 2026 report that people with pancreatic cancer and their families should understand, and what those numbers can and cannot say about one person's outlook.

Rasonque (daraxonrasib), the first approved drug to directly target RAS in pancreatic cancer, nearly doubled survival in a key trial. Two patients, a caregiver and the professionals who care for people like them explain what it means to live with the disease.
Advertisement
Advertisement
Trending on CURE
1
Pregnancy After Cancer: More Survivors Are Giving Birth
2
A Couple Faces Bladder Cancer Together, With a Nurse as Care Partner
3
How Areola Tattooing Can Help Breast Cancer Survivors After Reconstruction
4
Living With a New RAS-Targeted Drug for Pancreatic Cancer
5

